These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31806264)

  • 21. Long term effects of intra-articular botulinum toxin A for refractory joint pain.
    Mahowald ML; Singh JA; Dykstra D
    Neurotox Res; 2006 Apr; 9(2-3):179-88. PubMed ID: 16785116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical correction for lower lid epiblepharon in Asians.
    Woo KI; Yi K; Kim YD
    Br J Ophthalmol; 2000 Dec; 84(12):1407-10. PubMed ID: 11090483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction of epiblepharon of the upper eyelid by the buried suture technique: correlation with morphological features of the upper eyelid.
    Lew H; Yu SB; Yun YS; Lee SY
    Ophthalmologica; 2008; 222(2):100-4. PubMed ID: 18303230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type a for dysthyroid upper eyelid retraction.
    Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-specific difference in age distribution of congenital lower eyelid epiblepharon in a Japanese population.
    Valencia MRP; Takahashi Y; Nakakura S; Kakizaki H
    Jpn J Ophthalmol; 2019 Sep; 63(5):425-428. PubMed ID: 31286315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsurgical management of epiblepharon using hyaluronic acid gel.
    Naik MN; Ali MJ; Das S; Honavar SG
    Ophthalmic Plast Reconstr Surg; 2010; 26(3):215-7. PubMed ID: 20489553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of botulinum toxin type A in the management of neonatal brachial plexus palsy.
    Michaud LJ; Louden EJ; Lippert WC; Allgier AJ; Foad SL; Mehlman CT
    PM R; 2014 Dec; 6(12):1107-19. PubMed ID: 24798262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of botulinum A toxin in patients at risk of wound complications following eyelid reconstruction.
    Choi JC; Lucarelli MJ; Shore JW
    Ophthalmic Plast Reconstr Surg; 1997 Dec; 13(4):259-64. PubMed ID: 9430303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome.
    Laccourreye O; Akl E; Gutierrez-Fonseca R; Garcia D; Brasnu D; Bonan B
    Arch Otolaryngol Head Neck Surg; 1999 Mar; 125(3):283-6. PubMed ID: 10190799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orbicularis muscle fixation downward for the correction of congenital epiblepharon in Chinese patients.
    Tang W; Liang K; Xu Y; Tao L
    J Plast Reconstr Aesthet Surg; 2023 Oct; 85():159-164. PubMed ID: 37499556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No histological evidence of orbicularis oculi muscle hypertrophy in congenital epiblepharon.
    Kakizaki H; Takahashi Y; Kang H; Ikeda H; Iwaki M; Selva D; Leibovitch I
    Clin Exp Ophthalmol; 2013 Mar; 41(2):167-71. PubMed ID: 22712518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cosmetic indications for botulinum A toxin.
    Foster JA; Wulc AE; Holck DE
    Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.
    Mathevon L; Declemy A; Laffont I; Perennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):241-251. PubMed ID: 30980953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
    McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study.
    Träisk F; Tallstedt L
    Acta Ophthalmol Scand; 2001 Dec; 79(6):585-8. PubMed ID: 11782224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia.
    Mor N; Tang C; Blitzer A
    Otolaryngol Head Neck Surg; 2016 Sep; 155(3):458-61. PubMed ID: 27143711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.